Literature DB >> 24828651

Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.

Elizabeth G Mietlicki-Baase1, Pavel I Ortinski2, David J Reiner3, Christopher G Sinon4, James E McCutcheon4, R Christopher Pierce5, Mitchell F Roitman4, Matthew R Hayes1.   

Abstract

Glucagon-like peptide-1 receptor (GLP-1R) activation in the nucleus accumbens (NAc) core is pharmacologically and physiologically relevant for regulating palatable food intake. Here, we assess whether GLP-1R signaling in the NAc core of rats modulates GABAergic medium spiny neurons (MSNs) through presynaptic-glutamatergic and/or presynaptic-dopaminergic signaling to control feeding. First, ex vivo fast-scan cyclic voltammetry showed that the GLP-1R agonist exendin-4 (Ex-4) does not alter dopamine release in the NAc core. Instead, support for a glutamatergic mechanism was provided by ex vivo electrophysiological analyses showing that Ex-4 activates presynaptic GLP-1Rs in the NAc core to increase the activity of MSNs via a glutamatergic, AMPA/kainate receptor-mediated mechanism, indicated by increased mEPSC frequency and decreased paired pulse ratio in core MSNs. Only a small, direct excitatory effect on MSNs by Ex-4 was observed, suggesting that the contribution of postsynaptic GLP-1R to MSN activity is minimal. The behavioral relevance of the electrophysiological data was confirmed by the finding that intracore injection of the AMPA/kainate receptor antagonist CNQX attenuated the ability of NAc core GLP-1R activation by Ex-4 microinjection to suppress food intake and body weight gain; in contrast, intracore NMDA receptor blockade by AP-5 did not inhibit the energy balance effects of NAc core Ex-4. Together, these data provide evidence for a novel glutamatergic, but not dopaminergic, mechanism by which NAc core GLP-1Rs promote negative energy balance.
Copyright © 2014 the authors 0270-6474/14/346985-08$15.00/0.

Entities:  

Keywords:  VTA; diabetes; dopamine; energy balance; mesolimbic; obesity

Mesh:

Substances:

Year:  2014        PMID: 24828651      PMCID: PMC4019807          DOI: 10.1523/JNEUROSCI.0115-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments.

Authors:  V Bassareo; G Di Chiara
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

Authors:  Mary Parks; Curtis Rosebraugh
Journal:  N Engl J Med       Date:  2010-02-17       Impact factor: 91.245

3.  Projection neurons of the nucleus accumbens: an intracellular labeling study.

Authors:  H T Chang; S T Kitai
Journal:  Brain Res       Date:  1985-11-11       Impact factor: 3.252

4.  Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

Authors:  S B Floresco; C L Todd; A A Grace
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  Sucrose-predictive cues evoke greater phasic dopamine release than saccharin-predictive cues.

Authors:  James E McCutcheon; Jeff A Beeler; Mitchell F Roitman
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

6.  Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens.

Authors:  S R Jones; P A Garris; R M Wightman
Journal:  J Pharmacol Exp Ther       Date:  1995-07       Impact factor: 4.030

7.  Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens.

Authors:  Jonathan P Britt; Faiza Benaliouad; Ross A McDevitt; Garret D Stuber; Roy A Wise; Antonello Bonci
Journal:  Neuron       Date:  2012-11-21       Impact factor: 17.173

8.  GLP-1 analog attenuates cocaine reward.

Authors:  D L Graham; K Erreger; A Galli; G D Stanwood
Journal:  Mol Psychiatry       Date:  2012-10-23       Impact factor: 15.992

9.  CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputs.

Authors:  Kazunari Hisadome; Frank Reimann; Fiona M Gribble; Stefan Trapp
Journal:  Diabetes       Date:  2011-09-01       Impact factor: 9.461

10.  The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.

Authors:  Emil Egecioglu; Jörgen A Engel; Elisabet Jerlhag
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more
  50 in total

Review 1.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

2.  Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core.

Authors:  Samantha M Fortin; Mitchell F Roitman
Journal:  Physiol Behav       Date:  2017-03-16

Review 3.  PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.

Authors:  Stefan Trapp; Simon C Cork
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 4.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.

Authors:  Nicole S Hernandez; Bernadette O'Donovan; Pavel I Ortinski; Heath D Schmidt
Journal:  Addict Biol       Date:  2017-12-11       Impact factor: 4.280

6.  Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling.

Authors:  Zhi Yi Ong; Jing-Jing Liu; Zhiping P Pang; Harvey J Grill
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

7.  Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Authors:  Michal Taler; Israel Vered; Rea Globus; Liat Shbiro; Abraham Weizman; Aron Weller; Irit Gil-Ad
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

8.  Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons.

Authors:  Xue-Feng Wang; Jing-Jing Liu; Julia Xia; Ji Liu; Vincent Mirabella; Zhiping P Pang
Journal:  Cell Rep       Date:  2015-07-23       Impact factor: 9.423

9.  The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.

Authors:  Samantha M Fortin; Elena H Chartoff; Mitchell F Roitman
Journal:  Neuropsychopharmacology       Date:  2015-07-27       Impact factor: 7.853

10.  GLP-1 influences food and drug reward.

Authors:  Matthew R Hayes; Heath D Schmidt
Journal:  Curr Opin Behav Sci       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.